Quiver Bioscience
Cambridge, MA, United States quiverbioscience.com
From their website, Nov 2026
Work here? Claim this listing
About
Quiver Bioscience discovers CNS therapeutics using scalable human-relevant biology, all-optical electrophysiology, and AI-driven analysis. It works on neurological drug discovery for patients and partners, with activities centered in Cambridge, Massachusetts, USA.
Services
Patient-derived stem-cell models
Develops patient-derived stem-cell models to capture disease phenotypes and improve translatability.
In vitro assays
Runs in vitro assays as part of its scalable biology platform for neural disease and drug evaluation.
Ex vivo tissue slice assays
Uses ex vivo tissue slice assays to probe 3D neural circuits.
All-optical electrophysiology
Scalably measures neuron function at gold-standard resolution using all-optical electrophysiology.
AI-driven data analysis
Uses AI models to mine high-dimensional data to establish disease phenotypes, assess drug efficacy, match drugs to targets, and avoid unwanted toxicity.
Therapeutic target discovery
Identifies novel therapeutic targets for neurological disease programs.
Candidate molecule evaluation
Assesses efficacy and toxicity to identify the best candidate molecules for CNS programs.
AI/learning and surrogate models
Applies AI models to mine high-dimensional data for disease phenotypes, drug efficacy, target matching, and toxicity avoidance.
Target and molecule identification for CNS programs
Identifies therapeutic targets and candidate molecules for CNS drug discovery programs.
Capabilities
- Assays and studies
- Patch clamp · Small molecules · In vitro assays · Ex vivo tissue slice assays · All-optical electrophysiology
- Scale and capacity
- >10,000x throughput · 1B action potentials from >25M neurons in <6 months · 9.6B+ action potentials from >126M neurons and counting · 9.6B+ action potentials from >126M neurons
- Therapeutic areas
- Neurological disease · CNS · Chronic pain · Dup15q syndrome · Developmental and epileptic encephalopathy · Fragile X syndrome · Tuberous sclerosis
Modalities and species
- Modalities
- Small molecule · Oligonucleotide
- Species and models
- Patient-derived stem-cell models · Ex vivo tissue slices · Neurons · Patient-derived stem cells · 3D neural circuits
Industries served
- CNS drug discovery
Locations
- Address
- 150 Cambridge Park Drive, Cambridge, MA 02140 USA
- Sites
- Cambridge, USA
Contacts
- Phone
- +1 (617) 396-3611
Similar labs
Work here? Claim this listing